Dayvigo

Product manufactured by Eisai Inc.

Application Nr Approved Date Route Status External Links
NDA212028 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Dayvigo Is Indicated For The Treatment Of Adult Patients With Insomnia, Characterized By Difficulties With Sleep Onset And/or Sleep Maintenance [See Clinical Studies ( 14.1 )] . Dayvigo Is An Orexin Receptor Antagonist Indicated For The Treatment Of Adult Patients With Insomnia, Characterized By Difficulties With Sleep Onset And/or Sleep Maintenance. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Lemborexant

Comments